Form 8-K · Current report
Corpay 8-K, filed Aug 5, 2026
- Filed
- CIK
- 0001175454
- Accession no.
- 0001175454-26-000045
Summary
Corpay reported second-quarter 2026 revenue of $1.3388 billion, up 21%, and adjusted earnings per diluted share of $7.00, up 36%, while GAAP net income fell 13% to $248.3 million after a $100 million charge for a preliminary FTC settlement. The company raised its full-year 2026 guidance.
Key points
- Organic revenue grew 10% in the second quarter of 2026.
- Adjusted EBITDA rose 24% to $767.2 million.
- Corpay expects third-quarter 2026 revenue of approximately $1.355 billion at the midpoint and adjusted net income per diluted share of $7.15 at the midpoint.
- Corpay repurchased 1 million shares for $321 million in the quarter and increased its revolving credit facility to $3.7 billion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On August 5, 2026, Corpay, Inc. (the "Company") issued a press release announcing its financial results for the three and six months ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1, which is incorporated by reference in its entirety. The information in this item, including Exhibit 99.1, is being furnished, not filed. Accordingly, the information in this item will not be incorporated by reference into any registration statement filed by Corpay, Inc. under the Securities Act of 1933, as amended, unless specifically identified as being incorporated into it by reference. Item 7.01 Regulation FD Disclosure. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.